ARCHIVES

Gleevec Improves Survival Of CML In Accelerated Phase

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

NCCAM Trial Tests Electroacupuncture for Delayed Nausea.

June 14, 2002

Detroit Center Formally Recognized As Comprehensive

August 4, 1978

Advisors tell NCI to rethink contracts for clinical trials cooperative group tissue banks

November 21, 2003

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013